fully control the high-profit links of the industry chain
Sodium Ibandronate Injection
【Generic Name】：Sodium Ibandronate Injection
【Medical Insurance Information】：National Medical Insurance Category B
【Pharmaceutical Form】：Concentrate for Solution for Infusion.
【Approval Number】：H20133076, H20133077
【Indication and Usage】：A bisphosphonate indicated for the treatment of bone pain in patients with cancer and bone metastases (when the cancer has spread to the bone), tumour-induced hypercalcaemia with or without metastases and osteoporosis.
【Shelf Life】：24 months
【Manufacturer】：Sichuan Meida Kangjiale Pharmaceutical Co., Ltd.
【Distributor】：Sichuan Huaao Pharmaceutical Industry Company